AI Medical Compendium Journal:
NEJM evidence

Showing 1 to 5 of 5 articles

Individualized Treatment Effect Prediction with Machine Learning - Salient Considerations.

NEJM evidence
BACKGROUND: Machine learning-based approaches that seek to accomplish individualized treatment effect prediction have gained traction; however, some salient challenges lack wider recognition.

An AI Predictive Model to Determine Who Benefits from ADT with Radiation: Working Smarter, Not Harder.

NEJM evidence
Whether you are a surgical, medical, or radiation oncologist, the care goals remain the same, that is, achieving a durable treatment response. For patients with localized intermediate-risk prostate cancer undergoing radiation treatment, identifying t...

Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer.

NEJM evidence
BACKGROUND: Androgen deprivation therapy (ADT) with radiotherapy can benefit patients with localized prostate cancer. However, ADT can negatively impact quality of life, and there remain no validated predictive models to guide its use. METHODS: We us...

Validation of a Salivary miRNA Signature of Endometriosis - Interim Data.

NEJM evidence
BACKGROUND: The discovery of a saliva-based micro–ribonucleic acid (miRNA) signature for endometriosis in 2022 opened up new perspectives for early and noninvasive diagnosis of the disease. The 109-miRNA saliva signature is the product of miRNA bioma...

Real-Time Artificial Intelligence-Based Optical Diagnosis of Neoplastic Polyps during Colonoscopy.

NEJM evidence
BACKGROUND: Artificial intelligence using computer-aided diagnosis (CADx) in real time with images acquired during colonoscopy may help colonoscopists distinguish between neoplastic polyps requiring removal and nonneoplastic polyps not requiring remo...